Found: 30
Select item for more details and to access through your institution.
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 4, p. 452, doi. 10.1093/nop/npae026
- By:
- Publication type:
- Article
Keratosis Pilaris–Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal Melanoma.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 6, p. 682, doi. 10.1001/jamadermatol.2024.1137
- By:
- Publication type:
- Article
Utility of next‐generation sequencing in the diagnosis of metastatic melanoma: A case report.
- Published in:
- Journal of Cutaneous Pathology, 2024, v. 51, n. 9, p. 644, doi. 10.1111/cup.14660
- By:
- Publication type:
- Article
BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
- Published in:
- Journal of Cutaneous Pathology, 2012, v. 39, n. 9, p. 821, doi. 10.1111/j.1600-0560.2012.01950.x
- By:
- Publication type:
- Article
Latest Developments in the Biology and Management of Uveal Melanoma.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 6, p. 509, doi. 10.1007/s11912-013-0348-y
- By:
- Publication type:
- Article
Editorial: Women in skin cancer vol II: 2022.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1253081
- By:
- Publication type:
- Article
Neoadjuvant Immunotherapy in Melanoma: Where We Are and Where We Aren't.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 10, p. 425
- By:
- Publication type:
- Article
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3630, doi. 10.3390/cancers15143630
- By:
- Publication type:
- Article
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6247, doi. 10.3390/cancers14246247
- By:
- Publication type:
- Article
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3292, doi. 10.3390/cancers13133292
- By:
- Publication type:
- Article
Adjuvant Ipilimumab in High-Risk Uveal Melanoma.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 152, doi. 10.3390/cancers11020152
- By:
- Publication type:
- Article
New Evidence for Neoadjuvant Therapy in Advanced Melanoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 3, p. 128
- By:
- Publication type:
- Article
The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2293, doi. 10.1002/cam4.3781
- By:
- Publication type:
- Article
Neonatal Sporotrichosis.
- Published in:
- Pediatric Dermatology, 2009, v. 26, n. 5, p. 563, doi. 10.1111/j.1525-1470.2009.00986.x
- By:
- Publication type:
- Article
Beyond BRAF<sup>V600</sup>: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 2, p. 508, doi. 10.1038/jid.2014.366
- By:
- Publication type:
- Article
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Obstacles to improving outcomes in the treatment of uveal melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Uveal melanoma: From diagnosis to treatment and the science in between.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 4, p. 799, doi. 10.1002/cncr.27790
- By:
- Publication type:
- Article
Leptomeningeal disease in uveal melanoma: a case series.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 714, doi. 10.1093/oncolo/oyad039
- By:
- Publication type:
- Article
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1001150
- By:
- Publication type:
- Article
Intermittent MEK inhibition for the treatment of metastatic uveal melanoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.975643
- By:
- Publication type:
- Article
Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.806501
- By:
- Publication type:
- Article
Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.853076
- By:
- Publication type:
- Article
Profile of selumetinib and its potential in the treatment of melanoma.
- Published in:
- OncoTargets & Therapy, 2014, v. 7, p. 1631, doi. 10.2147/OTT.S51596
- By:
- Publication type:
- Article
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1 AX driver mutations in melanoma and across the cancer spectrum.
- Published in:
- Pigment Cell & Melanoma Research, 2016, v. 29, n. 4, p. 470, doi. 10.1111/pcmr.12482
- By:
- Publication type:
- Article
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 975, doi. 10.1002/cncr.34004
- By:
- Publication type:
- Article
Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 3, p. 391, doi. 10.1002/cncr.33242
- By:
- Publication type:
- Article